Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Int Med Res ; 48(10): 300060520967830, 2020 Oct.
Article in English | MEDLINE | ID: mdl-33115311

ABSTRACT

Recently, there has been a trend toward minimizing opioid use in obese patients to prevent opioid-related postoperative complications. Moreover, the use of opioid-free anesthesia has received growing interest. This case series reports the use of simple opioid-free anesthesia consisting of a mixture of dexmedetomidine, ketamine, and lidocaine in an obese male patient undergoing laparoscopic bariatric surgery and an obese pregnant woman undergoing cesarean section. These cases indicate that opioid-free anesthesia can be safely administered to obese patients and provides effective pain control without any postoperative adverse outcomes.


Subject(s)
Anesthesia , Dexmedetomidine , Ketamine , Analgesics, Opioid , Cesarean Section , Double-Blind Method , Female , Humans , Lidocaine , Male , Obesity , Pain, Postoperative/drug therapy , Pain, Postoperative/prevention & control , Pregnancy , Syringes
4.
J Int Med Res ; 47(6): 2740-2745, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31068034

ABSTRACT

A 7-year-old child underwent surgical excision of a benign mesothelioma of the pleura near the right lower lung. Although insertion of a wire-reinforced endotracheal tube through the left main bronchus was attempted for one-lung ventilation to secure the surgical field of view, the attempt failed. Therefore, an endotracheal tube was inserted into the trachea, and an Arndt endobronchial blocker (Cook Medical, Bloomington, IN, USA) was placed in the right intermediate bronchus under bronchoscopic guidance to selectively block the right lower and middle lobes. The surgery was performed while ventilating the right upper lobe and left lung, and no specific intraoperative adverse events occurred.


Subject(s)
Bronchi/surgery , Intubation, Intratracheal/methods , Mesothelioma/surgery , One-Lung Ventilation/methods , Thoracic Surgery, Video-Assisted/methods , Child , Female , Humans , Mesothelioma/pathology , Prognosis
5.
J Int Med Res ; 46(12): 5303-5308, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30345858

ABSTRACT

Vasopressin is a locally-injected vasoconstrictor used to reduce bleeding during gynaecological surgery. However, even in these cases, vasopressin can induce adverse effects, including bradycardia, myocardial infarction and cardiac arrest. Elevated blood concentrations of vasopressin may induce the sympathoinhibitory reflex by increasing blood pressure and augment the sympathoinhibitory reflex by activating the area postrema. In addition, pneumoperitoneum formation needed for laparoscopy as well as physiological changes caused by steep Trendelenburg positions used during robotic surgeries may cause bradycardia. Shoulder braces used to prevent slipping from a steep Trendelenburg position may also be hazardous. This case report describes a 31-year-old female patient who underwent a scheduled robotic-assisted laparoscopic myomectomy in a steep Trendelenburg position. The patient experienced a cardiac arrest 2 min after the vasopressin injection and was treated accordingly. There were no abnormal findings on the postoperative laboratory studies, chest X-ray and electrocardiogram. The patient also had clear consciousness with no other notable symptoms. The patient was discharged on postoperative day 2. The report discusses the potential adverse effects of local vasopressin injection during robotic-assisted laparoscopic myomectomy.


Subject(s)
Heart Arrest/etiology , Laparoscopy/adverse effects , Leiomyoma/surgery , Robotic Surgical Procedures/adverse effects , Uterine Myomectomy/adverse effects , Uterine Neoplasms/surgery , Vasopressins/administration & dosage , Adult , Female , Gynecologic Surgical Procedures/adverse effects , Heart Arrest/pathology , Humans , Injections, Intramuscular , Leiomyoma/pathology , Uterine Neoplasms/pathology
6.
Korean J Anesthesiol ; 60(6): 408-15, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21738843

ABSTRACT

BACKGROUND: Ischemia reperfusion (IR) injury is a complex phenomenon that leads to organ dysfunction and causes primary liver failure following liver transplantation. We investigated whether an intravenous administration of magnesium before reperfusion can prevent or reduce IR injury. METHODS: Fifty-nine living donor liver transplant recipients were randomly assigned to an MG group (n = 31) or an NS group (n = 28). Each group was also divided in two groups based on the preoperative magnesium levels (normal: ≥ 0.70 mmol/L, low: < 0.70 mmol/L). The MG groups received 25 mg/kg of MgSO(4) mixed in 100 ml normal saline intravenously before reperfusion and the NS groups received an equal volume of normal saline. The levels of lactate, pH, arterial oxygen tension, and base excess were measured to assess reperfusion injury at five specific times, which were 10 min after the beginning of anhepatic phase, and 10, 30, 60 and 120 min after reperfusion. To evaluate postoperative organ function, the serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin and creatinine levels were measured at preoperative day 1, postoperative day 1 and 5. RESULTS: The blood lactate levels were significantly lower at 10, 30, 60 and 120 min after reperfusion in the MG groups compared to the NS groups. In addition, significantly higher blood lactate levels were observed in the NS group with preoperative hypomagnesemia than in MG groups. CONCLUSIONS: Magnesium administration before reperfusion of liver transplantation significantly reduces blood lactate levels. These findings suggest that magnesium treatment may have protective effects on IR injury during living donor liver transplantation.

SELECTION OF CITATIONS
SEARCH DETAIL
...